CO55 Radiographic Progression-Free Survival (RPFS) as a Surrogate Endpoint for Overall Survival (OS) in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (MCRPC): A Correlation Meta-Analysis
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.134
https://www.valueinhealthjournal.com/article/S1098-3015(22)02338-5/fulltext
Title :
CO55 Radiographic Progression-Free Survival (RPFS) as a Surrogate Endpoint for Overall Survival (OS) in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (MCRPC): A Correlation Meta-Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02338-5&doi=10.1016/j.jval.2022.09.134
First page :
Section Title :
Open access? :
No
Section Order :
10925